Literature DB >> 17687133

Drug-induced immune thrombocytopenia.

Richard H Aster1, Daniel W Bougie.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17687133     DOI: 10.1056/NEJMra066469

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  118 in total

1.  High-content live-cell imaging assay used to establish mechanism of trastuzumab emtansine (T-DM1)--mediated inhibition of platelet production.

Authors:  Jonathan N Thon; Matthew T Devine; Antonija Jurak Begonja; Jay Tibbitts; Joseph E Italiano
Journal:  Blood       Date:  2012-06-04       Impact factor: 22.113

2.  Identifying drugs that cause acute thrombocytopenia: an analysis using 3 distinct methods.

Authors:  Jessica A Reese; Xiaoning Li; Manfred Hauben; Richard H Aster; Daniel W Bougie; Brian R Curtis; James N George; Sara K Vesely
Journal:  Blood       Date:  2010-06-08       Impact factor: 22.113

3.  Effect of Continuous and Sequential Therapy among Veterans Receiving Daptomycin or Linezolid for Vancomycin-Resistant Enterococcus faecium Bacteremia.

Authors:  Nicholas S Britt; Emily M Potter; Nimish Patel; Molly E Steed
Journal:  Antimicrob Agents Chemother       Date:  2017-04-24       Impact factor: 5.191

4.  Closed headpiece of integrin αIIbβ3 and its complex with an αIIbβ3-specific antagonist that does not induce opening.

Authors:  Jieqing Zhu; Jianghai Zhu; Ana Negri; Davide Provasi; Marta Filizola; Barry S Coller; Timothy A Springer
Journal:  Blood       Date:  2010-08-02       Impact factor: 22.113

Review 5.  Hypersensitivity reaction and acute immune-mediated thrombocytopenia from oxaliplatin: two case reports and a review of the literature.

Authors:  Marnelli A Bautista; W Tait Stevens; Chien-Shing Chen; Brian R Curtis; Richard H Aster; Chung-Tsen Hsueh
Journal:  J Hematol Oncol       Date:  2010-03-26       Impact factor: 17.388

Review 6.  Integrins as therapeutic targets: lessons and opportunities.

Authors:  Dermot Cox; Marian Brennan; Niamh Moran
Journal:  Nat Rev Drug Discov       Date:  2010-10       Impact factor: 84.694

7.  Acute profound thrombocytopenia with second exposure to eptifibatide associated with a strong antibody reaction.

Authors:  Shariff Attaya; Yogendra Kanthi; Richard Aster; Keith McCrae
Journal:  Platelets       Date:  2009-02       Impact factor: 3.862

8.  Species-Specific Involvement of Integrin αIIbβ3 in a Monoclonal Antibody CH12 Triggers Off-Target Thrombocytopenia in Cynomolgus Monkeys.

Authors:  Yiting Zhang; Jianhua Sun; Minjia Tan; Yongzhen Liu; Qian Li; Hua Jiang; Huamao Wang; Zonghai Li; Wei Wan; Hualiang Jiang; Henglei Lu; Bingshun Wang; Jin Ren; Likun Gong
Journal:  Mol Ther       Date:  2018-04-07       Impact factor: 11.454

Review 9.  Adverse reactions to targeted and non-targeted chemotherapeutic drugs with emphasis on hypersensitivity responses and the invasive metastatic switch.

Authors:  Brian A Baldo; Nghia H Pham
Journal:  Cancer Metastasis Rev       Date:  2013-12       Impact factor: 9.264

Review 10.  Drug-induced thrombocytopenia: pathogenesis, evaluation, and management.

Authors:  James N George; Richard H Aster
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2009
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.